Probing the binding sites of antibiotic drugs doxorubicin and N-(trifluoroacetyl) doxorubicin with human and bovine serum albumins

PLoS ONE

Volumn 7, Issue 8, 2012, Pages

  Agudelo, Daniel ^a   Bourassa, Philippe ^a   Bruneau, Julie ^a   Bérubé, Gervais ^a   Asselin, Éric ^a   Tajmir Riahi, Heidar Ali ^a  

^a UNIVERSITÉ DU QUÉBEC À TROIS RIVIÈRES   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; BOVINE SERUM ALBUMIN; DOXORUBICIN; HUMAN SERUM ALBUMIN; HYDROGEN; N TRIFLUOROACETYLDOXORUBICIN;

ALPHA HELIX; ARTICLE; BINDING AFFINITY; BINDING SITE; CIRCULAR DICHROISM; COMPLEX FORMATION; COMPUTER PROGRAM; CONCENTRATION (PARAMETERS); DRUG PROTEIN BINDING; DRUG STRUCTURE; DRUG TRANSPORT; FLUORESCENCE SPECTROSCOPY; HYDROGEN BOND; HYDROPHILICITY; HYDROPHOBICITY; IN VITRO STUDY; INFRARED SPECTROSCOPY; MOLECULAR DOCKING; MOLECULAR MODEL; NUCLEOTIDE SEQUENCE; PROTEIN CONFORMATION; PROTEIN STABILITY; PROTEIN STRUCTURE;

ANIMALS; BINDING SITES; CATTLE; DOXORUBICIN; HUMANS; MODELS, MOLECULAR; PROTEIN BINDING; PROTEIN CONFORMATION; SERUM ALBUMIN;

EID: 84865307678     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0043814     Document Type: Article

References (49)

1. Carvalho C, Santos RX, Cardoso S, Correia S, Oliveira PJ, et al. (2009) Doxorubicin: the good, the bad and the ugly effect. Curr Med Chem 16: 3267-3285.
2. Choi KC, Bang JY, Kim C, Kim PI, Lee SR, et al. (2009) Antitumor effect of adriamycin-encapsulated nanoparticles of poly(dl-lactide-co-glycolide)-grafted dextran. J Pharmacol Sci 98: 2104-2112.
3. Minotti G, Menna P, Salvatorelli E, Cairo G, Gianni L, (2004) Anthracyclines: molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity. Pharmacol Rev 56: 185-229.
4. Kratz F, (2007) DOXO-EMCH (INNO-206): the first albumin-binding prodrug of doxorubicin to enter clinical trials. Expert Opin Invest Drugs 16: 855-866.
5. Li C, Wallace S, (2008) Polymer-drug conjugates: recent development in clinical oncology. Adv Drug Deliv Rev 60: 886-898.
6. Janes KA, Fresneau MP, Marazuela A, Fabra A, Alonso MJ, (2001) Chitosan nanoparticles as delivery systems for doxorubicin. J Control Release 73: 255-267.
7. Mitra S, Gaur U, Ghosh PC, Maitra AN, (2001) Tumour targeted delivery of encapsulated dextran-doxorubicin conjugate using chitosan nanoparticles as carrier. J Control Release 74: 317-323.
8. Son YJ, Jang JS, Cho YW, Chung H, Park RW, et al. (2003) Biodistribution and anti-tumor efficacy of doxorubicin loaded glycol-chitosan nanoaggregates by EPR effect. J Control Release 91: 135-145.
9. Tan ML, Choong PFM, Dass CR, (2009) Review: doxorubicin delivery systems based on chitosan for cancer therapy. J Pharm Pharmacol 61: 131-142.
10. Qi J, Yao P, He F, Yu C, Haung C, (2010) Nanoparticles with dextran/chitosan shell and BSA/chitosan core-doxorubicin loading and delivery. Intl J Pharm 393: 176-184.
11. Yokoe JI, Sakuragi S, Yamamoto K, Teragaki T, Ogawara KI, et al. (2008) Albumin-conjugated PEG liposome enhances tumor distribution of liposomal doxorubicin in rats. Int J Pharm 353: 28-34.
12. Kratz F, (2008) Albumin as a drug carrier: design of prodrugs, drug conjugates and nanoparticles. J Control Release 132: 171-183.
13. Carter DC, Ho JX, (1994) Structure of serum albumin. Adv Protein Chem 45: 153-203.
14. Peters T (1996) All about albumin. Biochemistry, Genetics and Medical Applications. Academic Press, San Diego.
15. He XM, Carter DC, (1992) Atomic structure and chemistry of human serum Albumin. Nature 358: 209-215.
16. Peters T, (1985) Serum albumin. Adv Protein Chem 37: 161-245.
17. Tayeh N, Rungassamy T, Albani JR, (2009) Fluorescence spectral resolution of tryptophan residues in bovine and human serum albumins. J Pharm Biomed Anal 50: 107-116.
18. Lakowicz JR (2006) In Principles of Fluorescence Spectroscopy. 3nd ed; Springer: New York.
19. Acton EM, Tong GL, (1981) Synthesis and preliminary antitumor evaluation of 5-iminodoxorubicin. J Med Chem 24: 669-673.
20. Bérubé G, Richardson VJ, Ford CHJ, (1991) Synthesis of new N-(trifluoroacethyl) doxorubicin. Synthetic Commun 21: 931-944.
21. Painter L, Harding MM, Beeby PJ, (1998) Synthesis and interaction with human serum albumin of the first 3,18-disub-stituted derivative of bilirubin. J Chem Soc Perkin Trans 18: 3041-3044.
22. Dousseau F, Therrien M, Pezolet M, (1989) On the spectral subtraction of water from the FT-IR spectra of aqueous solutions of proteins. Appl Spectrosc 43: 538-542.
23. Byler DM, Susi H, (1986) Examination of the secondary structure of proteins by deconvoluted FTIR spectra. Biopolymers 25: 469-487.
24. Beauchemin R, N'soukpoe-Kossi CN, Thomas TJ, Thomas T, Carpentier R, et al. (2007) Polyamine analogues bind human serum albumin. Biomacromolecules 8: 3177-3183.
25. Ahmed A, Tajmir-Riahi HA, Carpentier R, (1995) A quantitative secondary structure analysis of the 33 kDa extrinsic polypeptide of photosystem II by FTIR spectroscopy. FEBS Lett 363: 65-68.
26. Johnson WC, (1999) Analyzing protein circular dichroism spectra for accurate secondary structure. Proteins Struct Funct Genet 35: 307-312.
27. Sreerama N, Woddy RW, (2000) Estimation of protein secondary structure from circular dichroism spectra: Comparison of CONTIN, SELCON and CDSSTR methods with an expanded reference set. Anal Biochem 287: 252-260.
28. Dufour C, Dangles O, (2005) Flavonoid-serum albumin complexation:determination of binding constants and binding sites by fluorescence spectroscopy. Biochim Biophys Acta 1721: 164-173.
29. Froehlich E, Jennings JC, Sedaghat-Herati MR, Tajmir-Riahi (2009) Dendrimers bind human serum albumin. J Phys Chem B 113: 6986-6993.
30. He W, Li Y, Xue C, Hu Z, Chen X, et al. (2005) Effect of Chinese medicine alpinetin on the structure of human serum albumin. Bioorg Med Chem 13: 1837-1845.
31. Jiang M, Xie M X, Zheng D, Liu Y, Li XY, et al. (2004) Spectroscopic studies on the interaction of cinnamic acid and its hydroxyl derivatives with human serum albumin. J Mol Struct 692: 71-80.
32. Bi S, Ding L, Tian Y, Song D, Zhou X, et al. (2004) Investigation of the interaction between flavonoids and human serum albumin. J Mol Struct 703: 37-45.
33. Belatik A, Hotchandani S, Bariyanga J, Tajmir-Riahi HA, (2012) Binding sites of retinol and retinoic acid with serum albumins. Europ J Med Chem 48: 114-123.
34. Arnold K, Bordoli A K, Kopp L, Schwede T, (2006) A web-based environment for protein structure homology modeling. Bioinformatics 22: 195-201.
35. Rost B, (1999) Twilight zone of protein sequence alignment. Protein Engineering 12: 85-94.
36. Sugio S, Kashima A, Mochizuki S, Noda M, Kobayashi K, (1999) Crystal structure of human serum albumin at 2.5 Å resolution. Protein Engineering 12: 439-446.
37. Schwede T, Kopp J, Guex N, Peitsch MC, (2003) SWISS-MODEL: an automated protein homology-modeling server. Nucl Acids Res 31: 3381-3385.
38. Krimm S, Bandekar J, (1986) Vibrational spectroscopy and conformation of peptides, polypeptides, and proteins. Adv Protein Chem 38: 181-364.
39. Ahmed Ouameur A, Diamantoglou S, Sedaghat-Herati MR, Nafisi Sh, Carpentier R, et al. (2006) An overview of drug binding to human serum albumin: Protein folding and unfolding. Cell Biochem Biophys 45: 203-213.
40. Tian J, Liu J, Hu Z, Chen X, (2005) Binding of the scutellarin to albumin using tryptophan fluorescence quenching, CD and FT-IR spectra. Am J Immunol 1: 21-23.
41. Grdadolnik J, (2003) Saturation effects in FTIR spectroscopy:intensity of amide I and amide II bands in protein spectra. Acta Chim Slov 50: 777-788.
42. Kragh-Hansen U, (1990) Structure and ligand binding properties of human serum albumin. Dan Med Bull 37: 57-84.
43. Kratochwil NA, Huber W, Muller F, Kansy M, Gerber PR, (2002) Predicting plasma protein binding of drugs: a new approach. Biochem Pharmacol 64: 1355-1374.
44. Zhang G, Que Q, Pan J, Guo J, (2008) Study of the interaction between icariin and human serum albumin by fluorescence spectroscopy. J Mol Struct 881: 132-138.
45. Charbonneau D, Beauregard M, Tajmir-Riahi HA, (2009) Structural analysis of human serum albumin complexes with cationic lipids. J Phys Chem B 113: 1777-1784.
46. Mandeville JS, Froehlich E, Tajmir-Riahi HA, (2009) Study of curcumin and genistein interactions with human serum albumin. J Pharm Biomed Anal 49: 468-474.
47. Mandeville JS, Tajmir-Riahi HA, (2010) Complexes of dendrimers with bovine serum albumin. Biomacromolecules 11: 465-472.
48. Dubeau S, Bourassa P, Thomas TJ, Tajmir-Riahi HA, (2010) Biogenic and synthetic polyamines bind bovine serum albumin. Biomacromolecules 11: 1507-1515.
49. Belatik A, Hotchandani S, Carpentier R, Tajmir-Riahi HA (2012) Locating the binding sites of Pb(II) ion with human and bovine serum albumins. PLoS ONE 7: e36723, 1-9.